Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

15.200
-0.670-4.22%
Volume:2.77M
Turnover:42.77M
Market Cap:6.57B
PE:2.30K
High:16.050
Open:15.910
Low:15.190
Close:15.870
52wk High:48.800
52wk Low:14.820
Shares:432.00M
HK Float Shares:323.00M
Volume Ratio:0.68
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.007
ROE:0.21%
ROA:-0.83%
PB:3.83
PE(LYR):2,303.03
PS:13.01

Loading ...

CF PharmTech Repurchases 17,500 H-Shares, Treasury Stock Rises to 753,000 Shares

Bulletin Express
·
May 14

CF PHARMTECH (02652) Spends HK$344,000 on Share Buyback on May 13

Stock News
·
May 13

CF Pharmtech files HKEX return disclosing share buyback at HKD 20.88 per share

Reuters
·
May 13

CF PharmTech buys back 11,500 H-shares, bringing treasury stock to 719,000

Bulletin Express
·
May 12

CF PHARMTECH (02652) Repurchases 8,500 Shares for HK$186,000 on May 11

Stock News
·
May 11

CF PharmTech repurchases 8,500 H-shares; treasury stock rises to 0.71 million

Bulletin Express
·
May 11

CF Pharmtech files HKEX return disclosing share buyback at HKD 21.93 each

Reuters
·
May 11

CF PharmTech repurchases 11,500 H-shares, expanding treasury stock to 699,000 units

Bulletin Express
·
May 08

CF PharmTech buys back 10,500 H-shares at HKD 21.71 average; treasury stock climbs to 0.69 million shares

Bulletin Express
·
May 07

CF PHARMTECH (02652) Repurchases 10,500 Shares for HK$228,000 on May 7

Stock News
·
May 07

CF Pharmtech files HKEX next-day disclosure, repurchases shares at HKD 21.71 each

Reuters
·
May 07

CF PharmTech Discloses April 2026 Share Capital Update; 0.16 Million H-Shares Added to Treasury

Bulletin Express
·
May 07

CF PHARMTECH (02652) Allocates HK$144,400 for Share Buyback on May 5

Stock News
·
May 05

CF Pharmtech files HKEX disclosure return, repurchases shares at HKD 22.22 each

Reuters
·
May 05

CF PharmTech repurchases 5,500 H shares; treasury holdings climb to 0.22% of issued shares

Bulletin Express
·
May 04

CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$123,000 on May 4

Stock News
·
May 04

CF Pharmtech files HKEX next-day return disclosing share repurchase at HKD 22.45

Reuters
·
May 04

14 Innovative Class 1 Drugs Receive Clinical Trial Approval in China from CF Pharmtech, Hengrui Pharma, and Others

Stock News
·
May 03

CF PHARMTECH 2025年营收同比下降、利润下滑逾八成,净资产同比大幅提升

Bulletin Express
·
Apr 30

CF PharmTech Releases 2025 ESG Report: Revenue at RMB 432.52 Million, Net Profit Turns Positive, R&D Spend Hits RMB 124.55 Million

Bulletin Express
·
Apr 30